The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artemisinine Market Research Report 2025
Synopsis
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinine market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 78 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
This report aims to provide a comprehensive presentation of the global market for Artemisinine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinine.
Report Scope
The Artemisinine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segment by Application
Injections
Tablets
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemisinine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinine market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 78 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
This report aims to provide a comprehensive presentation of the global market for Artemisinine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinine.
Report Scope
The Artemisinine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segment by Application
Injections
Tablets
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemisinine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artemisinine Market Overview
1.1 Product Overview and Scope of Artemisinine
1.2 Artemisinine Segment by Type
1.2.1 Global Artemisinine Market Value Comparison by Type (2024-2030)
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinine
1.3 Artemisinine Segment by Application
1.3.1 Global Artemisinine Market Value by Application: (2024-2030)
1.3.2 Injections
1.3.3 Tablets
1.3.4 Others
1.4 Global Artemisinine Market Size Estimates and Forecasts
1.4.1 Global Artemisinine Revenue 2019-2030
1.4.2 Global Artemisinine Sales 2019-2030
1.4.3 Global Artemisinine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artemisinine Market Competition by Manufacturers
2.1 Global Artemisinine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artemisinine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artemisinine Average Price by Manufacturers (2019-2024)
2.4 Global Artemisinine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artemisinine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artemisinine, Product Type & Application
2.7 Artemisinine Market Competitive Situation and Trends
2.7.1 Artemisinine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artemisinine Players Market Share by Revenue
2.7.3 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artemisinine Retrospective Market Scenario by Region
3.1 Global Artemisinine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artemisinine Global Artemisinine Sales by Region: 2019-2030
3.2.1 Global Artemisinine Sales by Region: 2019-2024
3.2.2 Global Artemisinine Sales by Region: 2025-2030
3.3 Global Artemisinine Global Artemisinine Revenue by Region: 2019-2030
3.3.1 Global Artemisinine Revenue by Region: 2019-2024
3.3.2 Global Artemisinine Revenue by Region: 2025-2030
3.4 North America Artemisinine Market Facts & Figures by Country
3.4.1 North America Artemisinine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artemisinine Sales by Country (2019-2030)
3.4.3 North America Artemisinine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artemisinine Market Facts & Figures by Country
3.5.1 Europe Artemisinine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artemisinine Sales by Country (2019-2030)
3.5.3 Europe Artemisinine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artemisinine Market Facts & Figures by Country
3.6.1 Asia Pacific Artemisinine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artemisinine Sales by Country (2019-2030)
3.6.3 Asia Pacific Artemisinine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artemisinine Market Facts & Figures by Country
3.7.1 Latin America Artemisinine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artemisinine Sales by Country (2019-2030)
3.7.3 Latin America Artemisinine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artemisinine Market Facts & Figures by Country
3.8.1 Middle East and Africa Artemisinine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artemisinine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artemisinine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artemisinine Sales by Type (2019-2030)
4.1.1 Global Artemisinine Sales by Type (2019-2024)
4.1.2 Global Artemisinine Sales by Type (2025-2030)
4.1.3 Global Artemisinine Sales Market Share by Type (2019-2030)
4.2 Global Artemisinine Revenue by Type (2019-2030)
4.2.1 Global Artemisinine Revenue by Type (2019-2024)
4.2.2 Global Artemisinine Revenue by Type (2025-2030)
4.2.3 Global Artemisinine Revenue Market Share by Type (2019-2030)
4.3 Global Artemisinine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artemisinine Sales by Application (2019-2030)
5.1.1 Global Artemisinine Sales by Application (2019-2024)
5.1.2 Global Artemisinine Sales by Application (2025-2030)
5.1.3 Global Artemisinine Sales Market Share by Application (2019-2030)
5.2 Global Artemisinine Revenue by Application (2019-2030)
5.2.1 Global Artemisinine Revenue by Application (2019-2024)
5.2.2 Global Artemisinine Revenue by Application (2025-2030)
5.2.3 Global Artemisinine Revenue Market Share by Application (2019-2030)
5.3 Global Artemisinine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Guilin Pharmaceutical
6.1.1 Guilin Pharmaceutical Corporation Information
6.1.2 Guilin Pharmaceutical Description and Business Overview
6.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Guilin Pharmaceutical Artemisinine Product Portfolio
6.1.5 Guilin Pharmaceutical Recent Developments/Updates
6.2 CAT KHANH
6.2.1 CAT KHANH Corporation Information
6.2.2 CAT KHANH Description and Business Overview
6.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CAT KHANH Artemisinine Product Portfolio
6.2.5 CAT KHANH Recent Developments/Updates
6.3 Novanat Bioresource
6.3.1 Novanat Bioresource Corporation Information
6.3.2 Novanat Bioresource Description and Business Overview
6.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novanat Bioresource Artemisinine Product Portfolio
6.3.5 Novanat Bioresource Recent Developments/Updates
6.4 BEEPZ
6.4.1 BEEPZ Corporation Information
6.4.2 BEEPZ Description and Business Overview
6.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BEEPZ Artemisinine Product Portfolio
6.4.5 BEEPZ Recent Developments/Updates
6.5 KPC Pharmaceuticals
6.5.1 KPC Pharmaceuticals Corporation Information
6.5.2 KPC Pharmaceuticals Description and Business Overview
6.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 KPC Pharmaceuticals Artemisinine Product Portfolio
6.5.5 KPC Pharmaceuticals Recent Developments/Updates
6.6 BIONEXX
6.6.1 BIONEXX Corporation Information
6.6.2 BIONEXX Description and Business Overview
6.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BIONEXX Artemisinine Product Portfolio
6.6.5 BIONEXX Recent Developments/Updates
6.7 Guangxi xiancaotang
6.6.1 Guangxi xiancaotang Corporation Information
6.6.2 Guangxi xiancaotang Description and Business Overview
6.6.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangxi xiancaotang Artemisinine Product Portfolio
6.7.5 Guangxi xiancaotang Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Artemisinine Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Natural Bio-engineering
6.9.1 Natural Bio-engineering Corporation Information
6.9.2 Natural Bio-engineering Description and Business Overview
6.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Natural Bio-engineering Artemisinine Product Portfolio
6.9.5 Natural Bio-engineering Recent Developments/Updates
6.10 Kerui nanhai
6.10.1 Kerui nanhai Corporation Information
6.10.2 Kerui nanhai Description and Business Overview
6.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kerui nanhai Artemisinine Product Portfolio
6.10.5 Kerui nanhai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artemisinine Industry Chain Analysis
7.2 Artemisinine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artemisinine Production Mode & Process
7.4 Artemisinine Sales and Marketing
7.4.1 Artemisinine Sales Channels
7.4.2 Artemisinine Distributors
7.5 Artemisinine Customers
8 Artemisinine Market Dynamics
8.1 Artemisinine Industry Trends
8.2 Artemisinine Market Drivers
8.3 Artemisinine Market Challenges
8.4 Artemisinine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
